Mercaptopurine
Mercaptopurine is a nucleoside metabolic inhibitor indicated for the treatment of patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen.
United States
$41
per month
India
$7
per month
You save
−84%save $34/mo · 84% cheaper
43.1K US scripts/yr$1.5M potential annual savings$1.8M US spend/yr
Drag to rotate · 3D structureC5H4N4S
SMILES: C1=NC2=C(N1)C(=S)N=CN2
Compare the price
US price$41per month
India price$7per month
You save$3484% less
Based on 30 units per month. US $1.36 vs India $0.22 per unit.
Total over 1 periodSave $34$41 → $7
The bigger picture
Mercaptopurine is filled about 43.1K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$1.8M
If sourced from India
$283K
Potential annual savings
$1.5M
−84%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.